TY - JOUR
T1 - Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes
AU - Cusi, Kenneth J.
AU - Pratipanawatr, Thongchai
AU - Koval, Janice
AU - Printz, Richard
AU - Ardehali, Hossein
AU - Granner, Darryl K.
AU - DeFronzo, Ralph A.
AU - Mandarino, Lawrence J.
N1 - Funding Information:
Supported by National Institutes of Health Grants No. DK47936 (to L.J.M.), DK24092 (to R.A.D.) a Veterans Administration Merit Award (to R.A.D.), DK35107 and DK46867 (to D.K.G.), DK20593 (Vanderbilt Diabetes Research and Training Center), and RR-01346 (General Clinical Research Center [GCRC], Audie L. Murphy Veterans Hospital).
PY - 2001/5
Y1 - 2001/5
N2 - Glucose phosphorylation, catalyzed by hexokinase, is the first committed step in glucose uptake in skeletal muscle. Hexokinase II (HKII) is the isoform that is present in muscle and is regulated by insulin and muscle contraction. Glucose phosphorylation and HKII expression are both reduced in obese and type 2 diabetic subjects. A single bout of exercise increases HKII mRNA and activity in muscle from healthy subjects. The present study was performed to determine if a moderate exercise increases HKII mRNA expression and activity in patients with type 2 diabetes. Muscle biopsies were performed before and 3 hours after a single bout of cycle ergometer exercise in obese and type 2 diabetic patients. HKII mRNA and activity and glycogen synthase activity were determined in the muscle biopsies. Exercise increased HKII mRNA in obese and diabetic subjects by 1.67 ± 0.34 and 1.87 ± 0.26-fold, respectively (P < .05 for both). Exercise did not significantly increase HKI mRNA. When HKII mRNA increases were compared with the 2.26 ± 0.36-fold increase in HKII mRNA previously reported for healthy lean subjects, no statistically significant differences were found. In contrast to the increase in HKII activity observed after exercise by lean healthy controls, exercise did not increase HKII activity in obese nondiabetic or diabetic subjects. Exercise increased glycogen synthase activity (GS0.1 and GSFV) significantly in both obese nondiabetic and type 2 diabetic patients. The present results indicate that there is a posttranscriptional defect in the response of HKII expression to exercise in obese and type 2 diabetic subjects. This defect may contribute to reduced HKII activity and glucose uptake in these patients.
AB - Glucose phosphorylation, catalyzed by hexokinase, is the first committed step in glucose uptake in skeletal muscle. Hexokinase II (HKII) is the isoform that is present in muscle and is regulated by insulin and muscle contraction. Glucose phosphorylation and HKII expression are both reduced in obese and type 2 diabetic subjects. A single bout of exercise increases HKII mRNA and activity in muscle from healthy subjects. The present study was performed to determine if a moderate exercise increases HKII mRNA expression and activity in patients with type 2 diabetes. Muscle biopsies were performed before and 3 hours after a single bout of cycle ergometer exercise in obese and type 2 diabetic patients. HKII mRNA and activity and glycogen synthase activity were determined in the muscle biopsies. Exercise increased HKII mRNA in obese and diabetic subjects by 1.67 ± 0.34 and 1.87 ± 0.26-fold, respectively (P < .05 for both). Exercise did not significantly increase HKI mRNA. When HKII mRNA increases were compared with the 2.26 ± 0.36-fold increase in HKII mRNA previously reported for healthy lean subjects, no statistically significant differences were found. In contrast to the increase in HKII activity observed after exercise by lean healthy controls, exercise did not increase HKII activity in obese nondiabetic or diabetic subjects. Exercise increased glycogen synthase activity (GS0.1 and GSFV) significantly in both obese nondiabetic and type 2 diabetic patients. The present results indicate that there is a posttranscriptional defect in the response of HKII expression to exercise in obese and type 2 diabetic subjects. This defect may contribute to reduced HKII activity and glucose uptake in these patients.
UR - http://www.scopus.com/inward/record.url?scp=0035340550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035340550&partnerID=8YFLogxK
U2 - 10.1053/meta.2001.22568
DO - 10.1053/meta.2001.22568
M3 - Article
C2 - 11319725
AN - SCOPUS:0035340550
SN - 0026-0495
VL - 50
SP - 602
EP - 606
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 5
ER -